Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design
EM Plummer, M Manchester - Wiley Interdisciplinary Reviews …, 2011 - Wiley Online Library
Current vaccines that provide protection against infectious diseases have primarily relied on
attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid …
attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid …
[HTML][HTML] Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design
EM Plummer, M Manchester - Wiley Interdisciplinary Reviews …, 2011 - ncbi.nlm.nih.gov
Current vaccines that provide protection against infectious diseases have primarily relied on
attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid …
attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid …
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.
EM Plummer, M Manchester - Wiley Interdisciplinary reviews …, 2010 - europepmc.org
Current vaccines that provide protection against infectious diseases have primarily relied on
attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid …
attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid …
Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design
EM Plummer, M Manchester - WIREs Nanomedicine and …, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Current vaccines that provide protection
against infectious diseases have primarily relied on attenuated or inactivated pathogens …
against infectious diseases have primarily relied on attenuated or inactivated pathogens …
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
EM Plummer, M Manchester - Wiley interdisciplinary …, 2011 - pubmed.ncbi.nlm.nih.gov
Current vaccines that provide protection against infectious diseases have primarily relied on
attenuated or inactivated pathogens. Virus-like particles (VLPs), comprised of capsid …
attenuated or inactivated pathogens. Virus-like particles (VLPs), comprised of capsid …
[PDF][PDF] Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
EM Plummer, M Manchester - tarjomefa.com
The goal of vaccination is to initiate a strong immune response that leads to the
development of lasting and protective immunity. Vaccines against pathogens are the most …
development of lasting and protective immunity. Vaccines against pathogens are the most …
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
EM Plummer, M Manchester - Wiley Interdisciplinary Reviews …, 2011 - hero.epa.gov
Current vaccines that provide protection against infectious diseases have primarily relied on
attenuated or inactivated pathogens. Virus-like particles (VLPs), comprised of capsid …
attenuated or inactivated pathogens. Virus-like particles (VLPs), comprised of capsid …
[PDF][PDF] Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
EM Plummer, M Manchester - tarjomefa.com
The goal of vaccination is to initiate a strong immune response that leads to the
development of lasting and protective immunity. Vaccines against pathogens are the most …
development of lasting and protective immunity. Vaccines against pathogens are the most …